Cardiac DRUGS Flashcards
Outline the process of platelet plug formation & inhibition
- Platelets (1a,1b,2b,3a) adhere to damaged subendothelium
- 1a - Collagen 1,2&3
- 1b - vWF & microfibrils
- 2b/3a - vWF & fibrinogen
- Form monolayer, spheres & release a & b granules
- ⇒ ADP, thromboxane A2 & 5HT
- ⇒ Aggregation & vasoconstriction
- Inhibited by PGI2 & NO
- Inhibits vasoconstriction
- Inhibits ADP, TcA2 & 5HT release
Outline the class & mechanism of Aspirin
Antiplatelet drug
- Blocks thromboxane A2 pathway of platelet activation by irreversibly acetylating cyclo-oxygenase
- Effects exist for lifespan of platelet (8-9d)
What are the indications for Aspirin
- Primary prevention - less clear due to bleeding risk, only in high risk pts
- Secondary prevention - ALL CV disease
- AF: 75-300mg
Outline the adverse affects/ risk factors/ contraindications of Aspirin
- Bronchospasm in up to 20% asthmatic adults [caution]
-
Gastric side-effects
- Nausea ⇒ GI bleeds
- Bleeding from Duodenal > Gastric ulcers
- [Active/recent ulcer/ bleeding contraindicate]
- Prophylaxis with PPIs should be considered if Hx
- Nausea ⇒ GI bleeds
- Any bleeding disorder contraindicate
*
What is Aspirin resistance?
- 10% of pts
- Affects effectiveness of Aspirin
- Testing of platelet activity not common so rarely identified
What drug interactions occur with Aspirin
- Analgesics: concomitant use
- Anticoagulands: bleeding risk
- Antidepressents: bleeding with
- SSRIs
- Venlafaxine
- Cytotoxics: aspirin reduces excretion of methotrexate
Outline the mechanism of Thienopyridines
Thienopyridines mechanism;
- Irreversibly block the binding of ADP to platelet reception
- ⇒ Prevent expression of the active glycoprotein IIb/IIa receptor
Give examples of thienopyridines
- Ticlopidine (first)
- Clopidogrel
- Prasugrel
- Ticagrelor
Outline the class & mechanims of Clopidogrel
Thienopyridine, mechanism;
- Irreversibly block the binding of ADP to platelet reception
- ⇒ Prevent expression of the active glycoprotein IIb/IIa receptor
What are the indications for Clopidogrel?
Indications;
- 2º prevention of CV events
- post-MI/ post-stroke/ **PVD **(75mg)
- post-PCI + stent insertion (+ Aspirin, 300-600mg loading dose, 75mg)
-
ACS
- +Aspirin
- 300-600mg loading dose, 75mg
Outline contraindications & cautions & adverse effects for Clopedigrel
Contraindications
- Hypersensitivity
- Bleeding problems
- Severe hepatic impairment
Cautions
- Bleeding risk
- Renal impairment
Adverse effects
- **Skin rash **(distinguish from self-limiting X-ray contrast-media-induced skin rash which occurs 1wk post PCI)
- GI side effects
- Bleeding & bruising
Outline the class & mechanism of Prasugrel
Compare to Clopidogrel
Thienopyridine, mechanism;
- Irreversibly block the binding of ADP to platelet reception
- ⇒ Prevent expression of the active glycoprotein IIb/IIa receptor
Compared to Cloppidogrel;
- **Earlier onset of anti-aggregatory effects **(<½hr) & less inter-patient varibility
- P is better in ACS & diabetics
- P is worse in stroke/ TIA (contraindication)
What are the indications for Prasugrel?
Outling dosing
- **1º or delayed PCI **for ACS
- Stent thrombosis during clopidogrel therapy
- Diabetes
Dosing;
- 60mg loading, 10mg
- 5mg in <60kg >75yrs
Outline contraindications & cautions & adverse effects of Prasugrel
Contraindications;
- Hx of CVA/ TIA
- Hypersensitivity
- Bleeding problems
- Severe hepatic impairment
Cautions
- Bleeding risk
- Renal impairment
- Pregnancy & lactation
Adverse effects
- Skin rash (distinguish from self-limiting X-ray contrast-media-induced skin rash which occurs 1wk post PCI)
- GI side effects
- Bleeding & bruising
Outline examples and mechanism of actions of Glycoprotein IIb/IIIa receptor inhibitors
- Abcliximab
- Monoclonal AB
- Eptifibatise/ tirofiban
- Small-molecule GPIIb/IIIa inhibitors
Outline the mechanism of action of Eptifibatise
Outline its indiations
IV antiplatelet agent: Small-molecule GPIIb/IIIa receptor inhibitor
Indication:
- Prevention of early MI in patients presenting with ACS
Outline the mechanism of action of Tirofiban
Outline its indiations
IV antiplatelet agent: Small-molecule GPIIb/IIIa receptor inhibitor
Indication:
- Prevention of early MI in patients presenting with ACS
Outline the mechanism of action of Abiciximab
Outline its indiations
Intravenous antiplatelet agent: Monoclonal AB
Indications;
- Pre-PCI: prevents ischaemic complications
Outline the mechanism of action of angiotensin-converting enzyme inhibitors
Outline AG2 function
ACEi block conversion of Angiotensin 1 to Angiotensin 2.
Angiotensin 2 functions;
- Massive vasoconstriction
- ADH secretion from posterior pituitary
- Aldosterone secretion from adrenal gland cortex
- Sympathetic activity increase
- Renal
- Na+Cl- reabsorption in proximal tubule (and hence H2O)
- K+ exretion